Pfizer Newsroom

Jefferies Maintains Pfizer(PFE.US) With Buy Rating, Cuts Target Price to $33

Futu NewsSep 27 20:32

Jefferies Maintains Pfizer(PFE.US) With Buy Rating, Cuts Target Price to $33

Futu NewsSep 27 15:33

Jefferies Remains a Buy on Pfizer (PFE)

TipRanksSep 27 15:07

A Quick Look at Today's Ratings for Pfizer(PFE.US), With a Forecast Between $30 to $36

Futu NewsSep 26 21:03

Pfizer's Solid Fundamentals and Strategic Acquisitions Affirm Buy Rating Despite Oxbryta Setback

TipRanksSep 26 19:18

Pfizer's Investment Outlook: A Cautious Hold Amid Oxbryta Withdrawal and Mixed Acquisition Results

TipRanksSep 26 06:57

Guggenheim Adjusts Price Target on Pfizer to $36 From $35, Maintains Buy Rating

MT NewswiresSep 24 19:17

Jefferies Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $35

Futu NewsSep 23 20:33

Jefferies Sticks to Its Buy Rating for Pfizer (PFE)

TipRanksSep 23 20:30

Jefferies Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $35

Futu NewsSep 17 20:34

Pfizer (PFE) Receives a Buy From Jefferies

TipRanksSep 17 20:19

Cantor Fitzgerald Reiterates Overweight on Pfizer, Maintains $45 Price Target

BenzingaSep 17 00:26

Pfizer Analyst Ratings

BenzingaSep 17 00:25

BMO Capital Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $36

Futu NewsSep 14 04:31

Pfizer Analyst Ratings

BenzingaSep 9 23:57

Cantor Fitzgerald Reiterates Overweight on Pfizer, Maintains $45 Price Target

BenzingaSep 9 23:56

Erste Group Initiates Pfizer(PFE.US) With Hold Rating

Futu NewsSep 5 20:33

Berenberg Bank Reaffirms Their Hold Rating on Pfizer (PFE)

TipRanksAug 23 18:27

Pfizer Analyst Ratings

BenzingaAug 20 00:30

Cantor Fitzgerald Reiterates Overweight on Pfizer, Maintains $45 Price Target

BenzingaAug 20 00:29